Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
180
archived clinical trials in
Hair Loss

Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Northwest Dermatology
mi
from
Portland, OR
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Northwest Dermatology
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Suzanne Bruce & Associates, PA
mi
from
Houston, TX
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Suzanne Bruce & Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Siperstein Dermatology Group
mi
from
Boynton Beach, FL
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Siperstein Dermatology Group
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Encinitas, CA
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Encinitas, CA
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Redwood City, CA
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Redwood City, CA
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Washington,
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Washington,
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Boston, MA
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Clinton Township, MI
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Warren, MI
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Warren, MI
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Fridley, MN
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Fridley, MN
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Omaha, NE
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
New York, NY
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Durham, NC
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Portland, OR
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Austin, TX
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
San Antonio, TX
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Laguna Hills, CA
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Miami, FL
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Minneapolis, MN
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Winston-Salem, NC
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Nashville, TN
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Fort Washington, PA
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Fort Washington, PA
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Boynton Beach, FL
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Knoxville, TN
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered for 3 Months in Adult Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Fractional Photothermolysis for Hair Follicle Induction
Fractional Photothermolysis for the Treatment of Hair Loss
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine, Department of Dermatology, Dermatology Clinical Research Center, Hewitt Hall
mi
from
Irvine, CA
Fractional Photothermolysis for Hair Follicle Induction
Fractional Photothermolysis for the Treatment of Hair Loss
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine, Department of Dermatology, Dermatology Clinical Research Center, Hewitt Hall
mi
from
Irvine, CA
Click here to add this to my saved trials
Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
A Randomized Controlled Trial Comparing Platelet Rich Plasma (PRP) to Minoxidil Foam for Treatment of Androgenic Alopecia in Women
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
A Randomized Controlled Trial Comparing Platelet Rich Plasma (PRP) to Minoxidil Foam for Treatment of Androgenic Alopecia in Women
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
An Open-Label Pilot Study of the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily in Adult Subjects With Eyebrow Loss Due to Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Boynton Beach, FL
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
An Open-Label Pilot Study of the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily in Adult Subjects With Eyebrow Loss Due to Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Boynton Beach, FL
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Nashville, TN
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Austin, TX
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
San Antonio, TX
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Hot Springs, AR
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Hot Springs, AR
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Rogers, AR
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Rogers, AR
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Denver, CO
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Miami, FL
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Sanford, FL
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Sanford, FL
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Snellville, GA
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Snellville, GA
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Clinton Township, MI
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Clinton Township, MI
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Detroit, MI
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Detroit, MI
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Fridley, MN
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Fridley, MN
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Minneapolis, MN
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Saint Joseph, MO
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Omaha, NE
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Las Vegas, NV
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
New York, NY
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Rochester, NY
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
mi
from
Portland, OR
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Portland, OR
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Greenville, SC
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Greenville, SC
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from
Knoxville, TN
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials